• Malaria, vaccines & biologics

    Progress toward developing malaria vaccines and biologics has accelerated in recent years. Increased funding and awareness and advances in science and in vaccine technologies have reinvigorated a field that had been constrained by an absence of a traditional market, few developers, and the technical complexity of developing any vaccine or biologic against a parasite. Even with this progress, the field needs new ideas, more funding, and innovative partnerships.